Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
SGLT2 Inhibitors and GLP1 Agonists Administered Without Metformin Compared to Other Glucose-Lowering Drugs in Patients With Type 2 Diabetes Mellitus to Prevent Cardiovascular Events: A Systematic ReviewDiabet. Med. 2020 Dec 23;[EPub Ahead of Print], C Escobar, V Barrios, J Cosín, JM Gámez Martínez, AI Huelmos Rodrigo, C Ortíz Cortés, J Torres Llergo, C Requeijo, I Solà, MJ Martínez Zapata
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.